Aspreva Pharmaceuticals Corp.
Autoimmune disease drug maker completes raises $57 million
Published in Medical Device Business Week, April 7th, 2004
Sprout Group, one of the oldest and largest U.S. institutional venture capital firms and an affiliate of Credit Suisse First Boston, led the investment with significant participation from InterWest Partners, a large diversified venture capital firm. Other investors in the international syndicate included HBM Partners, Thomas Weisel Healthcare Ventures, BioAsia Investments, LLC, and Axiom Venture Partners.
This financing, one of the largest series A financings reported in North America, consists of $53 million in venture capital funds and $4.2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- AVI BioPharma, Inc.
Neugene maker reports quarterly loss of $0.10 per share - Alfacell Corporation
Savadelis named chief financial officer at pharmaceutical firm - American Oriental Bioengineering
Bioengineering firm expects record revenue growth, income for 2003 - Avitar, Inc.
Diagnostics company announces second closing of private placement - BioRexis Pharmaceutical Corp.
Biopharmaceutical firm completes $30M series B financing - Business & Finance
Scripps Research Institute plans Florida research hospital - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
